WoundSource Practice Accelerator: Diabetic Foot Ulcers

 

Test your knowledge based on your learning from the materials provided in the WoundSource Practice Accelerator program on Diabetic Foot Ulcers.

Of patients with diabetic foot ulcer (DFU), nearly 20% will experience the following:

The pathology of DFU results from a combination of (select all that apply):

During a foot examination, the clinician encounters a deformity of the left second toe where the distal and proximal interphalangeal joints are flexed, causing the distal tip of the toe to point downward; callus formation is also noted at the distal tip of the toe where it comes into contact with the ground during ambulation. How should this condition be documented?

Which of the following assessments in a patient with DFU indicates the potential need for antibiotics?

Prepared cellular and/or tissue-based products (CTPs) include (Select all that apply):

Utilizing advanced therapies for treatment of DFU should be considered when:

What percentage of patients will die within five years of receiving diagnosis of DFU?

Management of blood glucose, hypertension, fluid volume or edema, and nutrition in patients with DFU is part of:

Which of the following is NOT considered an advanced wound therapy in the treatment of DFU?

Which of the following is the best intervention for prevention of DFU and subsequent amputation?